The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA.
AUTOR(ES)
Taylor, J W
RESUMO
M13 RF IV DNA may be prepared in vitro to contain phosphorothioate-modified internucleotidic linkages in the (-)strand only. Certain restriction enzymes react with this modified DNA to hydrolyze the (+)strand exclusively when a phosphorothioate linkage occurs at the normal cleavage point in the (-)strand. The reaction of Pvu I with M13mp2 RF IV DNA containing dCMPS residues in the (-)strand is of this type, and is exploited to allow subsequent digestion with exonuclease III of a portion of the (+)strand opposite different mutagenic mismatched oligonucleotide primers. Two methods are described by which this approach has been used to produce mutations in M13mp2 phage DNA with high efficiency as a result of simple and rapid in vitro manipulations. Plaques containing mutant phage in a genetically-pure form are obtained at a frequency of 40-66%, allowing their characterisation directly by sequence analysis without prior screening and plaque purification. The wide applicability of this approach is discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=318950Documentos Relacionados
- The use of phosphorothioate-modified DNA in restriction enzyme reactions to prepare nicked DNA.
- 5'-3' exonucleases in phosphorothioate-based oligonucleotide-directed mutagenesis.
- High-efficiency oligonucleotide-directed plasmid mutagenesis.
- Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.
- Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA.